Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Biocon reports earnings

Biocon (NSE:BIOCONEQ) reported an operating profit of Rs. 486 million

Read the full 104 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE